0001839516-22-000002.txt : 20220311 0001839516-22-000002.hdr.sgml : 20220311 20220311160713 ACCESSION NUMBER: 0001839516-22-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220309 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Whitfield Dianne C. CENTRAL INDEX KEY: 0001839516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 22733192 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD, SUITE 160 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 4 1 wf-form4_164703276995746.xml FORM 4 X0306 4 2022-03-09 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001839516 Whitfield Dianne C. C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 0 1 0 0 Chief Human Resources Officer Stock Option (right to buy) 19.59 2022-03-09 4 A 0 60846 0 A 2032-03-08 Common Stock 60846.0 60846 D Restricted Stock Units 2022-03-09 4 A 0 17850 0 A Common Stock 17850.0 17850 D Restricted Stock Units 2022-03-09 4 A 0 34171 0 A Common Stock 34171.0 34171 D 25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. 30% of the RSUs will vest on November 29, 2022 and 70% of the RSUs will vest on November 29, 2023, subject to the Reporting Person's continuous service. /s/ Leonard M. Greenstein, Attorney-in-Fact 2022-03-11